The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...

The non-invasive therapy signals a strategic push into the growing home healthcare market for post-surgical rehabilitation.

Women's HRT patches can treat prostate cancer just as effectively as standard hormone injections—but with fewer of the worst ...

Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...

For men who have a detectable PSA of 0.5 ng/mL or less after radical prostatectomy and before salvage radiation therapy, hormone therapy may provide no overall survival or metastasis-free survival ...

Radium 223 without androgen deprivation therapy (ADT) in patients (Pts) with biochemically recurrent prostate cancer (BCR) and PET findings in the bones. This is an ASCO Meeting Abstract from the 2026 ...

SAN FRANCISCO -- Adding hormone therapy to postoperative radiotherapy did not improve overall survival (OS) for most men with prostate cancer, according to a meta-analysis of individual patient data.

Just three months after further scaling back its support for the struggling hemophilia A gene therapy Roctavian, BioMarin is walking away altogether by pulling the treatment from the market. The move ...

For men with a localized recurrence following prostate cancer radiotherapy, salvage treatment with either focal therapy or surgery may offer comparable long-term cancer control, but focal therapy ...

Boehringer Ingelheim is discarding an inhaled gene therapy designed to treat cystic fibrosis (CF) after terminating a phase 1/2 trial. The shuttered study, dubbed Lenticlair 1, failed to produce ...

Reviewing the Dewalt cordless vacuum after one year of use. Fox host asks Vance if US.-born Olympian should lose status skiing for China 4 dead in pile-up crash involving over 30 vehicles, including ...